News Website

Exploring Causal Associations Between Serum Inflammatory Markers and Female Reproductive Disorders: A Mendelian Randomisation Study.

Although inflammation may disrupt immunoendocrine crosstalk essential for female reproductive function, causal links to disorders like polycystic ovary syndrome (PCOS) and endometriosis remain unestablished. This study aimed to utilise Mendelian …

Published: Dec. 2, 2024, midnight

Read Full Article

endometriosis inflammation interleukins mendelian randomisation monocyte chemoattractant protein-1/C-C motif ligand-2 (MCP-1/CCL2) polycystic ovary syndrome (PCOS)

Australians with endometriosis to have access to cheaper treatment for the first time in three decades - Women's Agenda

Australians with endometriosis to have access to cheaper treatment for the first time in three decades Women's Agenda

Published: Dec. 1, 2024, 11:50 p.m.

Read Full Article

‘Women are suffering’: Endometriosis treatment to be subsidised in 30-year first - Women's Health

‘Women are suffering’: Endometriosis treatment to be subsidised in 30-year first Women's Health

Published: Dec. 1, 2024, 11:49 p.m.

Read Full Article

Life-Changing Endometriosis Treatment To Be Subsidised In ‘Transformative’ Move - Pedestrian.TV

Life-Changing Endometriosis Treatment To Be Subsidised In ‘Transformative’ Move Pedestrian.TV

Published: Dec. 1, 2024, 11:36 p.m.

Read Full Article

New treatment offers hope for Aussies with endometriosis - ABC News

New treatment offers hope for Aussies with endometriosis ABC News

Published: Dec. 1, 2024, 8 p.m.

Read Full Article

'It's completely changed my life': endometriosis patients hail new subsidised treatment - Head Topics

'It's completely changed my life': endometriosis patients hail new subsidised treatment Head Topics

Published: Dec. 1, 2024, 9:32 a.m.

Read Full Article

Cheaper endometriosis treatment: 9News Latest Stories Season 2024, Short Video - 9Now

Cheaper endometriosis treatment: 9News Latest Stories Season 2024, Short Video 9Now

Published: Dec. 1, 2024, 9:08 a.m.

Read Full Article

"It's completely changed my life": endometriosis patients hail new subsidised treatment - SBS News

"It's completely changed my life": endometriosis patients hail new subsidised treatment SBS News

Published: Dec. 1, 2024, 7:43 a.m.

Read Full Article

Life changing endometrisosis treatment now cheaper - Department of Health

Life changing endometrisosis treatment now cheaper Department of Health

Published: Dec. 1, 2024, 1:55 a.m.

Read Full Article

Differential diagnosis of ovarian endometriosis cyst versus ovarian cystadenoma based on serum lactate dehydrogenase combined with CA-125 and CA19-9: A retrospective cohort study.

This study aims to construct and validate a nomogram for the differential diagnosis of ovarian endometriosis cyst versus ovarian cystadenoma. We retrospectively studied the clinical characteristics of patients with ovarian …

Published: Dec. 1, 2024, midnight

Read Full Article

Latest Articles

Exploring Causal Associations Between Serum Inflammatory Markers and Female Reproductive Disorders: A Mendelian Randomisation Study.

Australians with endometriosis to have access to cheaper treatment for the first time in three decades - Women's Agenda

‘Women are suffering’: Endometriosis treatment to be subsidised in 30-year first - Women's Health

Life-Changing Endometriosis Treatment To Be Subsidised In ‘Transformative’ Move - Pedestrian.TV

New treatment offers hope for Aussies with endometriosis - ABC News

'It's completely changed my life': endometriosis patients hail new subsidised treatment - Head Topics

Cheaper endometriosis treatment: 9News Latest Stories Season 2024, Short Video - 9Now

"It's completely changed my life": endometriosis patients hail new subsidised treatment - SBS News

Life changing endometrisosis treatment now cheaper - Department of Health

Differential diagnosis of ovarian endometriosis cyst versus ovarian cystadenoma based on serum lactate dehydrogenase combined with CA-125 and CA19-9: A retrospective cohort study.

Subscribe to Our Newsletter